BioVersys AG (XSWX:BIOV) Scaled Net Operating Assets: -0.01 (As of Dec. 2025)


XSWX:BIOV BioVersys AG XSWX:BIOV
4 GF Score
Price CHF26.00
View Full Analysis

What is BioVersys AG Scaled Net Operating Assets?

BioVersys AG XSWX:BIOV 4 Scaled Net Operating Assets is -0.01 as of Dec. 2025. GuruFocus rates XSWX:BIOV with a GF Score™ of 4/100.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioVersys AG's operating assets for the quarter that ended in Dec. 2025 was CHF8.13 Mil. BioVersys AG's operating liabilities for the quarter that ended in Dec. 2025 was CHF9.10 Mil. BioVersys AG's Total Assets for the quarter that ended in Jun. 2025 was CHF94.72 Mil. Therefore, BioVersys AG's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was -0.01.

BioVersys AG Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for BioVersys AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVersys AG Scaled Net Operating Assets Chart

BioVersys AG Annual Data
Trend Dec24 Dec25
Scaled Net Operating Assets
-0.14 -0.03

BioVersys AG Semi-Annual Data
Jun24 Dec24 Jun25 Dec25
Scaled Net Operating Assets 0.00 0.00 -0.11 -0.01

XSWX:BIOV vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, BioVersys AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVersys AG Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVersys AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BioVersys AG's Scaled Net Operating Assets falls into.


XSWX:BIOV
4GF Score
BioVersys AG XSWX:BIOV
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioVersys AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioVersys AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(8.131-9.096)/34.956
=-0.03

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=90.636 - 82.505
=8.131

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=30.825 - 21.44 - 0.289
=9.096

BioVersys AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Jun. 2025 )
=(8.131-9.096)/94.722
=-0.01

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=90.636 - 82.505
=8.131

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=30.825 - 21.44 - 0.289
=9.096

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.01 mean?
BioVersys AG (XSWX:BIOV) has a Scaled Net Operating Assets of -0.01 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on BioVersys AG and its competitors.
Is BioVersys AG's Scaled Net Operating Assets too high?
BioVersys AG's current Scaled Net Operating Assets is -0.01. Overall, BioVersys AG has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's Scaled Net Operating Assets compare to VRTX and REGN?
BioVersys AG's Scaled Net Operating Assets of -0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on BioVersys AG and its competitors. BioVersys AG's current Scaled Net Operating Assets is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (XSWX:BIOV) has a current Scaled Net Operating Assets of -0.01. The current Scaled Net Operating Assets is -0.01. BioVersys AG's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For BioVersys AG (XSWX:BIOV), the current Scaled Net Operating Assets is -0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioVersys AG Business Description

Other Exchanges BIOVz:UKW33:Germany
Address c/o Technologiepark, Hochbergerstrasse 60c, Basel, CHE, CH-4057
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
4GF Score

Get the complete analysis for XSWX:BIOV

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF26.00
Price